The research is promising
This research is extremely promising, and relatively unprecedented. As a result, it is crucial that further research be conducted to confirm the initial findings. If studies in the future prove the efficacy and safety of quorum-sensing inhibitors, it is possible that soon enough they could be available to patients who are taking Kalydeco or Orkambi as supplements to ensure the best possible outcome of the treatments. For those who feel there is little to no advancement being made in their therapies, this would be an extremely exciting prospect. Many are already looking forward to it.